Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Nash Finch Q4 Reported Profit Plunges - Quick Facts

Nash-Finch Co.'s (NAFC: Quote) fourth-quarter 2011 reported net earnings plummeted to $8.2 million or $0.62 per share from last year's $16.9 million, or $1.30 per share.

Excluding items, adjusted net earnings decreased to $12.7 million or $0.97 per share from $13.1 million or $1.00 per share in the 2010 period. On average, 2 analysts polled by Thomson Reuters expected earnings per share of $0.82 for the quarter. Analysts' estimates typically exclude one-time items.

Total company sales for the 2011 fourth quarter were $1.14 billion compared with $1.15 billion in the prior-year quarter, down 0.9%. Excluding the impact of selling or closing seven retail stores, total company quarterly comparable sales rose 0.1% relative to the earlier year period.

Click here to receive FREE breaking news email alerts for Nash Finch Co and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.